HETEROCYCLIC COMPOUNDS, PREPARATION METHODS AND USES THEREOF
摘要:
Provided herein are novel compounds, for example, compounds having a Formula (I), a prodrug thereof, or a pharmaceutically acceptable salt thereof. Also provided herein are pharmaceutical compositions comprising a compound having a Formula (I), a prodrug thereof, or a pharmaceutically acceptable salt thereof, methods of preparing the compounds and methods of using the compounds, for example, in inhibiting KIF18A in a cell, and/or in treating various cancers associated with KIF18A protein.
HETEROCYCLIC COMPOUNDS, PREPARATION METHODS AND USES THEREOF
摘要:
Provided herein are novel compounds, for example, compounds having a Formula (I), a prodrug thereof, or a pharmaceutically acceptable salt thereof. Also provided herein are pharmaceutical compositions comprising a compound having a Formula (I), a prodrug thereof, or a pharmaceutically acceptable salt thereof, methods of preparing the compounds and methods of using the compounds, for example, in inhibiting KIF18A in a cell, and/or in treating various cancers associated with KIF18A protein.
[EN] TRIAZOLOPYRIDINE COMPOUNDS<br/>[FR] COMPOSÉS DE TRIAZOLOPYRIDINE
申请人:HOFFMANN LA ROCHE
公开号:WO2012163724A1
公开(公告)日:2012-12-06
The present invention relates to the use of novel triazolopyridine derivatives of formula I: wherein all variable substituents are defined as described herein, which are SYK inhibitors and are useful for the treatment of auto-immune and inflammatory diseases.